CGH analysis of secondary genetic changes in Ewing tumors: correlation with metastatic disease in a series of 43 cases

被引:30
作者
Brisset, S
Schleiermacher, G
Peter, M
Mairal, A
Oberlin, O
Delattre, O
Aurias, A
机构
[1] Inst Curie, Lab Pathol Mol Canc, Sect Rech, INSERM,U509, F-75248 Paris 05, France
[2] Inst Gustave Roussy, Villejuif, France
关键词
D O I
10.1016/S0165-4608(01)00454-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The occurrence of secondary chromosome changes is frequent in Ewing tumors, in particular trisomies for chromosomes 8 and 12, and unbalanced (1; 16) translocations leading to gains of 1q and losses of 16q. The prognostic value of these secondary aberrations has not been statistically demonstrated. We report here a CGH analysis of a series of 43 primary tumors corresponding to 21 localized and 22 metastatic tumors. For five of them, a sufficient amount of DNA for the CGH analysis was available from the frozen samples. For 19 samples, a preliminary step of DOP-PCR amplification of the DNA was necessary. For the last 19 tumors, DNA was obtained after DOP-PCR amplification of small amount of DNA contaminating the RNA. As a whole, the main chromosome imbalances previously described, such as trisomies for 1q 8, and 12, were observed. It is noteworthy that the mean number of imbalances was more frequent in localized versus metastatic tumors. Gain of lq was more frequent in metastatic than in localized tumors. Nevertheless, these two results do not reach statistical significance. Conversely, a statistically significant excess of copy number of chromosome 2 was observed in non-metastatic tumors, suggesting that this imbalance, which has never been previously reported, could be associated with more favorable tumor behavior. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 16 条
[1]   Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization [J].
Armengol, G ;
Tarkkanen, M ;
Virolainen, M ;
Forus, A ;
Valle, J ;
Bohling, T ;
AskoSeljavaara, S ;
Blomqvist, C ;
Elomaa, I ;
Karaharju, E ;
Kivioja, AH ;
Siimes, MA ;
Tukiainen, E ;
Caballin, MR ;
Myklebost, O ;
Knuutila, S .
BRITISH JOURNAL OF CANCER, 1997, 75 (10) :1403-1409
[2]   EWS-FL11 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma [J].
de Alava, E ;
Kawai, A ;
Healey, JH ;
Fligman, I ;
Meyers, PA ;
Huvos, AG ;
Gerald, WL ;
Jhanwar, SC ;
Argani, P ;
Antonescu, CR ;
Pardo-Mindan, FJ ;
Ginsberg, J ;
Womer, R ;
Lawlor, ER ;
Wunder, J ;
Andrulis, I ;
Sorensen, PHB ;
Barr, FG ;
Ladanyi, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1248-1255
[3]   Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor [J].
Fagnou, C ;
Michon, J ;
Peter, M ;
Bernoux, A ;
Oberlin, O ;
Zucker, JM ;
Magdelenat, H ;
Delattre, O .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1707-1711
[4]  
Hattinger CM, 1999, GENE CHROMOSOME CANC, V24, P243, DOI 10.1002/(SICI)1098-2264(199903)24:3<243::AID-GCC10>3.0.CO
[5]  
2-A
[6]   OPTIMIZING COMPARATIVE GENOMIC HYBRIDIZATION FOR ANALYSIS OF DNA-SEQUENCE COPY NUMBER CHANGES IN SOLID TUMORS [J].
KALLIONIEMI, OP ;
KALLIONIEMI, A ;
PIPER, J ;
ISOLA, J ;
WALDMAN, FM ;
GRAY, JW ;
PINKEL, D .
GENES CHROMOSOMES & CANCER, 1994, 10 (04) :231-243
[7]  
Kuukasjarvi T, 1997, GENE CHROMOSOME CANC, V18, P94, DOI 10.1002/(SICI)1098-2264(199702)18:2<94::AID-GCC3>3.3.CO
[8]  
2-5
[9]   Frequency and implications of chromosome 8 and 12 gains in ewing sarcoma [J].
Maurici, D ;
Perez-Atayde, A ;
Grier, HE ;
Baldini, N ;
Serra, M ;
Fletcher, JA .
CANCER GENETICS AND CYTOGENETICS, 1998, 100 (02) :106-110
[10]  
SPEICHER MR, 1993, HUM MOL GENET, V2, P1907